LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Benign Thyroid Nodules Follow-Up Shows Favorable Prognosis

By LabMedica International staff writers
Posted on 24 Mar 2015
Image: Fine needle aspiration cytology of a thyroid nodule showing benign epithelial cells, colloid, and occasional macrophages, typical of a colloid nodule (Photo courtesy of Shahidul Islam, MD, PhD).
Image: Fine needle aspiration cytology of a thyroid nodule showing benign epithelial cells, colloid, and occasional macrophages, typical of a colloid nodule (Photo courtesy of Shahidul Islam, MD, PhD).
A majority of asymptomatic, benign thyroid nodules exhibited no significant change in size, after five years of follow-up, or actually decreased in size, and diagnoses of thyroid cancer were rare.

The discovery of a thyroid nodule may be stressful for the patient, but more than 90% of the detected nodules are clinically insignificant benign lesions. Fine-needle aspiration cytology is the procedure of choice to identify suspicious lesions that require thyroid surgery.

Scientists at the Università di Roma Sapienza (Rome, Italy) and colleagues studied the frequency, magnitude, and factors associated with changes in thyroid nodule size. The study involved 992 patients with one to four asymptomatic, sonographically or cytologically benign thyroid nodules. Patients were recruited from eight hospital-based thyroid-disease referral centers in Italy between 2006 and 2008. Data collected during the first five years of follow-up, through January 2013, were analyzed. Size changes were considered significant for growth if an increase of 20% or more was recorded in at least two nodule diameters, with a minimum increase of two mm.

Fine-needle aspiration was performed or repeated when suspicious findings such as hypoechogenicity, irregular margins, taller-than-wide shape, intranodular vascular spots, microcalcifications, developed subsequent to the baseline ultrasound examination. Thyroid function tests were also measured. Nodule growth occurred in 153 patients (15.4%) and 174 of the 1,567 original nodules (11.1%) increased in size. Nodule growth was associated with presence of multiple nodules. In 184 individuals (18.5%), nodules shrank. Thyroid cancer was diagnosed in five original nodules (0.3 %), only two of which had grown. New nodules developed in 93 patients (9.3%), with detection of one cancer.

The authors noted that one of the goals of surveillance is the prompt detection and treatment of thyroid cancers that arise during follow-up or have been missed on the initial assessment. In the population they studied, these events were rare. Only two of the five diagnoses of cancer in an established nodule were preceded by significant growth of the cancerous nodule. Among patients with asymptomatic thyroid nodules that were sonographically or cytologically benign, the majority of nodules exhibited no significant size change during five years of follow-up or they actually decreased in size. The study was published on March 3, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Università di Roma Sapienza


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Human Estradiol Assay
Human Estradiol CLIA Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more